Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis
2024 · Nature · 97 citations
https://doi.org/10.1038/s41586-023-06888-7
S
Shujun Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
2.4K
Citations
26
h-index
40
i10-index
Shujun Liu is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Pain Mechanisms and Treatments & Cancer, Lipids, and Metabolism & Healthcare and Venom Research. The author has an h-index of 26, co-authored 99 publications.
ORCID: 0000-0001-5650-0993Papers by this author
worksMulti-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer
2024 · Molecular Cancer · 36 citations
https://doi.org/10.1186/s12943-024-01945-9
Application of automated peritoneal dialysis in urgent-start peritoneal dialysis patients during the break-in period
2018 · International Urology and Nephrology · 26 citations
https://doi.org/10.1007/s11255-018-1785-1
Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients
2021 · Cancer Letters · 24 citations
https://doi.org/10.1016/j.canlet.2021.06.002
Association between acromegaly and a single nucleotide polymorphism (rs2854744) in the IGFBP3 gene
2018 · BMC Medical Genetics · 11 citations
https://doi.org/10.1186/s12881-018-0698-2
Real-time imaging of axonal membrane protein life cycles
2024 · Nature Protocols · 7 citations
https://doi.org/10.1038/s41596-024-00997-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat